Endo Pharmaceuticals is expanding
to bring new therapies to patients, new treatment approaches to physicians and better
outcomes to managed care providers. Today, we're working in pain management, urology,
endocrinology and oncology. We're evaluating new drug delivery technologies to create
innovative new medicines. We're empowering our commercial team to work with physicians
and payers to become real partners in medical care, not just suppliers. These are
exciting changes which move us closer to our goal of becoming the premier specialty
pharmaceutical company.
American Medical Systems (AMS) became a wholly
owned subsidiary of Endo Pharmaceuticals on June 20, 2011.
American Medical Systems is a diversified supplier of medical devices and procedures
to treat incontinence, erectile dysfunction, benign prostatic hyperplasia (BPH),
pelvic floor prolapse and other pelvic disorders in men and women. These disorders
can significantly diminish one's quality of life and profoundly affect social relationships.
In recent years, the number of people seeking treatment has increased markedly as
a result of longer lives, higher-quality-of-life expectations and greater awareness
of new treatment alternatives. American Medical Systems' products reduce or eliminate
the incapacitating effects of these diseases, often through minimally invasive therapies.
The Company's products were used to treat approximately 340,000 patients in 2010.
*By clicking on the link(s) on this page you will leave the Endo.com website and
move to an external website(s) independently operated and not managed by Endo Pharmaceuticals.
Because Endo Pharmaceuticals does not control the content of the website(s) you
are about to visit, and due to its constantly changing nature, we cannot be responsible
for its content, accuracy, practices, or standards.
